Introduction
Mexican data on cancer mortality had been reviewed over the period of 1970-1999 in a previous report (Malvezzi et al., 2004) , and in an overall report of cancer mortality in the Americas (Bosetti et al., 2005) . The key aspect of these data was that cancer mortality in Mexico has remained comparably low on an American and on a worldwide scale. Low mortality rates were observed for several major cancer sites, including mouth and pharynx, esophagus, colorectum, lung, breast, and prostate. Mortality from cancers of the colorectum, breast, ovary, prostate, and leukemias as well as for all neoplasms had been, however, increasing over the last decades. Gastric cancer rates were considerably higher than in North America, although they were relatively low compared with other Latin American countries, and showed substantial downward trends. In contrast, very high mortality rates were registered for cancer of the (cervix) uteri (14.8/100 000 women in 2000, world standard), reflecting a high incidence of the disease in this country (Arrossi et al., 2003) .
Other reports on mortality from selected neoplasms in Mexico for recent calendar periods reported decreasing trends for cancer of the lung (Tovar-Guzman et al., 2005) , inconsistent trends for cervical (Robles et al., 1996; Lazcano-Ponce et al., 2008) , stomach (Tovar-Guzman et al., 2001) , and prostate (Tovar-Guzman et al., 1999) cancers, and rising trends for breast (Lopez-Rios et al., 1997; Franco-Marina et al., 2009) and colorectal (Tovar-Guzman et al., 1998) cancers.
We have systematically updated cancer mortality from Mexico up to 2007, including joinpoint analysis to detect significant changes in trends (Kim et al., 2000) .
Methods
Certified deaths from 20 selected cancer sites and for total cancers for the period 1981-2007, stratified for sex and 5-year age groups, were derived from the World Health Organization database available on electronic support (World Health Organization Statistical Information System, 2010b) . Data for cancers of the gallbladder and bile ducts, pancreas, kidney, Hodgkin lymphomas (HL), non-Hodgkin lymphomas (NHL), and multiple myeloma (MM) were available only since 1998; and data for ovarian and testicular cancers were not available for the years 1981-1997. No extrapolations were made for missing years.
During the calendar period considered, two different revisions of the International Classification of Diseases (ICD) were used (World Health Organization, 1977 , 1992 . Classification of cancer deaths was thus recoded for all calendar periods according to the tenth revision of the ICD (World Health Organization, 1992). To reduce classification problems and to improve comparability of data, we pooled together all intestinal cancers (chiefly colon and rectum), all uterine cancers (cervix and corpus), and all leukemias. For liver, we considered primary neoplasms only (ICD-10, C22.0-C22.8). No reliable data were available for rare cancers (i.e. pleura, soft tissue sarcomas, and thyroid) and for a few other sites (e.g. brain) which involve major difficulties in diagnosis and certification. Data for bone and skin cancer were also excluded from this analysis, due to problems in the distinction between primary and metastatic neoplasms and in the reliability of certifications.
Estimates of the resident population, based on official censuses, were obtained from the same World Health Organization database (World Health Organization Statistical Information System, 2010b) for the period 1981-1995 and from the Pan American Health Organization (2008) for more recent years. As the Pan American Health Organization provided population data stratified by sex and 5-year age groups for 2000 and 2005 only, sex-specific and agespecific data for the remaining years were estimated.
From the matrices of certified deaths and resident population, age-specific rates for each 5-year age group (from 0 to 4, to 80 years or more) were computed. Agestandardized mortality rates per 100 000 men and women were computed using the direct method on the basis of the world standard population (Doll and Smith, 1982) .
Joinpoint regression analysis was used to identify points at which a significant change in the linear slope of the trend occurred (Kim et al., 2000) . In the joinpoint analysis, the best fitting points (the 'joinpoints') in which the rate changes significantly (increases or decreases) are chosen. The analysis starts with the minimum number of joinpoints (e.g. 0 joinpoints, which is a straight line on a log scale), and tests whether one or more joinpoints (up to 3) are significant and must be added to the model. The estimated annual percent change is then computed for each of these trends by fitting a regression line to the natural logarithm of the rates using calendar year as a regressor variable. The average annual percent change over the entire period ) -based on an underlying joinpoint model -was also estimated as the geometric weighted average of the various annual percent changes, with the weights equal to the lengths of each time interval segment (Clegg et al., 2009) . The joinpoint analyses were carried out using the 'Joinpoint' Software from the Surveillance Research Program of the US National Cancer Institute (National Cancer Institute, 2010). Table 1 gives the overall age-adjusted mortality rates from selected cancers per 100 000 men and women in Mexico in the periods 1985-1989, 1995-1999, and 2005-2007 , and the corresponding percent changes. Total cancer mortality in men was stable in the first decade considered, but decreased from 83.4 in 1995-1999 to 75.5/100 000 in 2005-2007 ( -9.4% ). In women, the declines were earlier and larger than in men from 81.8 in 1985-1989 to 69.2/100 000 in 2005-2007 (-4% in the first decade and -12% in the last one). In men, over the two decades, decreasing mortality trends were observed for cancers of the mouth and pharynx, esophagus, stomach, larynx, and lung. Over the last decade, mortality declined for gallbladder and bladder cancer, and for HL as well. Unfavorable trends were observed for colorectal, liver, and NHL. Prostate cancer rates increased between 1985-1989 and 1995-1999 and leveled off thereafter. Mortality from pancreatic and testicular cancer, MM, and leukemias was stable over the period considered. Similar patterns were observed for women, with declines over the last two decades in mortality from cancers of the esophagus, stomach, lung, and uterus, and over the last decade from gallbladder and pancreatic cancer. In contrast, death rates from colorectal, liver, and breast cancer increased between 1985-1989 and 2005-2007 , whereas mortality from ovarian cancer was stable over the period considered. Table 2 shows corresponding values for truncated rates at age 35-64 years. Favorable trends were observed for total cancer mortality in both sexes mostly over the last decade, with mortality rates declining from 90.2 in 1985-1989 to 80.5/100 000 in 2005-2007 for men, and from 125.8 in 1985-1989 to 106.0/100 000 in 2005-2007 for women. Patterns in cancer mortality in middle-aged adults were consistent with overall ones, with the exception of the decline in testicular cancer from 0.69 in 1995-1999 to 0.58/100 000 in 2005-2007. Although mortality rates from breast and uterine cancer were higher in middle-aged women than in the overall female population, trends over the last two decades were similar for both neoplasms.
Results
The findings from the joinpoint analysis for mortality from 11 selected cancers (overall and truncated 35-64 years) in Mexican men and women over the period 1981-2007 are given in Table 3 and Fig. 1 . For most cancers (and consequently for all cancers), mortality was upward in earlier calendar periods, but started to decline in the late 1980s or 1990s in both sexes. The major decline was observed for uterine cancer, by approximately 2.5% per year in the 1990s, and by approximately 5% per year in the last decade both at all ages and at the age of 35-64 years. Other major reductions over recent years in both sexes were those of stomach cancer (approximately 2.5% per year and 5% in men in the last years), lung (2-2.5% per year and 11% in men in the last years), and larynx (more than 5% per year in men in the last years). Mortality started to level off since the early 1990s for breast and prostate cancer, and since the late 1990s for colorectal cancer in both sexes.
Discussion
Death rates from cancer in Mexico remained low on a worldwide scale (Levi et al., 1999; Bosetti et al., 2005; Edwards et al., 2010; Ferlay et al., 2010; La Vecchia et al., 2010) and trends have been favorable over more recent calendar years for several major cancer sites, including tobacco-related ones. The low cancer mortality rates in Mexico compared with other countries of North but also Latin America may at least in part be due to bias related to systematic problems in population estimates, though valid census figures have long been available (Instituto Nacional de Estadistica y Geografia, July 2010), and/or to problems and validity of death certification. In recent years, all Mexican death certificates are checked and signed by a doctor, and the persistently low rates for several cancers in patients whose diagnosis does not pose major problems, such as those of the stomach, colorectum, lung, or breast, weigh against a major role in death certification validity. Moreover, there is no reason to suppose that quality and validity of death certification have worsened over the recent calendar period. Indeed, the estimated coverage of mortality data increased from 92.4 in 1999-2001 to 95.4% in 2002-2005 (World Health Organization Statistical Information System 2010b).
Mortality from cancers of the oral cavity, esophagus, and larynx in Mexico has long been low compared with North America (Edwards et al., 2010) and Europe (La Vecchia et al., 2010), but -as in several other countries -it showed favorable patterns since the late 1980s/early 1990s in men. No major trends were observed in women, who had, however, remarkably low rates. Mortality from those neoplasms is influenced by population exposure to their two major risk factors, that is, tobacco smoking and alcohol drinking. In 2002, the prevalence of current smokers was 36% in men and 13% in women (Secretaria de Salud de Mèxico, 2002) . However, among male current smokers, 63% reported to smoke less than five cigarettes per day, 19% reported to smoke 5-10 cigarettes per day, 12% reported to smoke 11-20 cigarettes per day, and only 6% reported to smoke more than 20 cigarettes per day. Thus, the burden of disease attributable to smoking has been estimated to be low (Samet, 2010) . Moreover, annual per capita cigarette consumption (Shafey et al., 2003) and prevalence of daily smokers has declined in Mexico over recent decades (Franco-Marina and Table 1 Age-adjusted mortality rates (world population) per 100 000 men and women in Mexico in 1985-1989, 1995-1999, and 2005-2007 (unless mentioned in parentheses) and corresponding percent changes in rates Men Women
Cancer site 1985-1989 1995-1999 2005-2007 
Number of deaths in 2007
Percent change (1995-1999/ 1985-1989) Percent change (2005-2007/ 1995-1999) 1985-1989 1995-1999 2005-2007 
Percent change (1995-1999/ 1985-1989) Percent change (2005-2007/ 1995-1999) Oral cavity, pharynx Lazcano-Ponce, 2010). Alcohol consumption increased between 1960 and 1980, but it has leveled off thereafter at approximately 5 l per year of ethanol per adult, that is, at comparably low levels on an international scale (World Health Organization Statistical Information System 2010a).
As in most areas of the world (Bertuccio et al., 2009; Edwards et al., 2010) , mortality from stomach cancer in Mexico has been steadily decreasing over the last few decades, and it is now lower than that observed in most other Latin American countries (Bosetti et al., 2005) as well as in central and eastern European ones (Bertuccio et al., 2009) , though still higher than in North America (Edwards et al., 2010) . This may be partially attributable to a high prevalence of Helicobacter pylori infection (Sicinschi et al., 2006) in this country, and/or to more recent introduction of an affluent diet and adequate food conservation (refrigeration; La Vecchia et al., 1990).
All intestinal cancers were pooled together because a large number of colorectal cancer deaths are classified as 'malignant neoplasms of other and ill-defined digestive organs' (ICD-10 = C26), and the distinction between colon and rectum may pose some difficulties as several cancers arise in the rectosigmoid junction (Boyle et al., 1985) . Despite a high prevalence of overweight and obesity in both sexes in Mexico (72% of women and 67% of men were overweight/obese in 2005) (Secretaria de Salud de Mèxico, 2006) , and the consequent high prevalence (27%) of patients with metabolic syndrome (Escobedo et al., 2009; Pelucchi et al., 2010) , colorectal cancer rates remained among the lowest on an American (Bosetti et al., 2005; Edwards et al., 2010) and on a worldwide scale (Levi et al., 1999; Center et al., 2009 ). This may be due to favorable aspects of the Mexican diet, poor in red and processed meat, and including mainly home-made dishes with beans, corn products, cereals, legumes, and tomatoes that may have positive effects on Table 2 Age-adjusted mortality rates (world population) per 100 000 men and women aged 35-64 years in Mexico in 1985 35-64 years in Mexico in -1989 35-64 years in Mexico in , 1995 35-64 years in Mexico in -1999 35-64 years in Mexico in , and 2005 35-64 years in Mexico in -2007 (unless mentioned in parentheses) and corresponding percent changes in rates Men Women
Percent change (1995-1999/ 1985-1989) Percent change (2005-2007/ 1995-1999) colorectal cancer risk (Mitchell et al., 2009; Reyes-Ortiz et al., 2009 ). An additional favorable factor is the relatively high physical activity by at least a proportion of the (rural) population (Ortiz-Hernandez and Ramos-Ibanez, 2010). The apparent increase in colorectal cancer mortality in the mid 1990s is at least in part due to changes in death certification and coding, although a tendency toward a more 'westernized' life style and dietary habits in the Mexican population may also have played a role (Tovar-Guzman et al., 1998; Center et al., 2009) .
Mortality data from (primary) liver cancer are extremely difficult to interpret, as the liver is one of the most common sites of secondaries, and the distinction between primary and metastatic liver cancer is variable according to calendar years and subsequent revisions of the ICD. Notwithstanding these cautions, mortality rates from liver cancer tended to increase in the last two decades, but remained comparatively low, with rates similar to those of North America (Edwards et al., 2010) and northern Europe (Bosetti et al., 2008a) . If not due to substantial problems in death certification, this would suggest that, apart from the relatively low alcohol consumption (World Health Organization Statistical Information System, 2010a), the prevalence of hepatitis B [approximately 1% (Roman et al., 2009 )] and C [generally less than 1% (Santos-Lopez et al., 2008)] is comparably low in Mexico.
In Mexico, as in other Latin American countries, gallbladder mortality was higher than in most developed areas of the world (Ferlay et al., 2010) , particularly in women, who have higher rates than men. Although mortality data from this neoplasm are available only since 1998, they show downward trends over the more recent years. The major recognized risk factor for gallbladder cancer is the presence of gallstones, which in turn are related to obesity, multiple pregnancies, and other hormonal factors (Randi et al., 2006) . Thus, the declines observed are likely due to an increase in the cholecystectomy rate over recent calendar years.
For lung cancer, low death rates were observed over recent decades in both sexes. These figures are likely to be a consequence of the low tobacco consumption (and in particular the limited frequency of heavy smokers) in the Mexican population (Secretaria de Salud de Mèxico, 2002) . Moreover, mortality from lung cancer has been declining over the last two decades in men, and over more recent years in women too, after the decrease in the consumption of tobacco in the Mexican population (Shafey et al., 2003; Tovar-Guzman et al., 2005) . Although it is unlikely that a major epidemic in lung cancer will occur in the near future, lung cancer remains the major cause of mortality from cancer in Mexico, and consequently a public health priority in this country.
Breast cancer mortality remained among the lowest in the American context (Bosetti et al., 2005; Edwards et al., 2010) and on a worldwide scale (Levi et al., 1999; Ferlay et al., 2010) . Some increase in the mortality rate has been observed up to the mid 1990s, but rates tended to level off over more recent years. Death certification for breast cancer is generally straightforward, and the persisting low rates for this neoplasm are therefore probably real. These figures may be partially explained by reproductive habits of subsequent cohorts of Mexican women (Lopez-Rios et al., 1997; Franco-Marina et al., 2009 ), whose fertility rates, though decreasing, remained comparatively high (3.4 births per woman in 1990 and 2.2 in 2007; World Health Organization, 2009) . Changes in life style and dietary habits in the last decades may have also had some impact in the increased mortality trends from this neoplasm over recent decades (Romieu and Lajous, 2009 ), whereas the more favorable trends in breast cancer mortality over the last decade are likely due to improvements in the diagnosis and treatment for this neoplasm (Jatoi and Miller, 2003) . Still, the majority of breast cancer cases in Mexico are self detected, only 10% of them are diagnosed at an early stage, and only a minority of middle-aged women reported having mammography in the previous year (Robles and Galanis, 2002; Franco-Marina et al., 2009; Knaul et al., 2009 ).
Although it is not possible to distinguish cervix from endometrial cancer based on the death certification, the substantial falls observed mainly in middle-aged women are likely due to cervical cancer, as endometrial cancer is rare in young women. Despite the favorable trends over the last decades, cervical cancer remains a major public health problem in Mexico, being the second cause of mortality from cancer after breast, with the highest rates among Latin American countries (Bosetti et al., 2005; Edwards et al., 2010; Ferlay et al., 2010) . This points to inadequate and delayed implementation of organized cervical screening programs (Lazcano-Ponce et al., 1996 ; Lazcano-Ponce and Allen-Leigh, 2009), and it consequently calls for an urgent intervention to reduce this largely avoidable cause of cancer death mainly in young women (Boyle et al., 2003) .
Ovarian cancer mortality has been constant in the last decade, at relatively low rates on a worldwide scale, but comparable with those of several southern European countries (Bray et al., 2005) . As for breast cancer, the high fertility rates in this population are likely to be the main reason for low mortality rates from ovarian cancer, which is inversely related to parity (La Vecchia, 2001) .
Prostate cancer mortality rates have been increasing up to the late 1990s, to level off only in most recent years, and remained lower than those found in North America and Europe (Edwards et al., 2010; La Vecchia et al., 2010) . Improved treatments for this neoplasm -including hormonal therapy (androgen blockage), radical prostatectomy, and radiotherapy -may have played a role in the recent favorable trends, particularly in middle-aged men for whom earlier declines were observed (Sharifi et al., 2005) , whereas the earlier rises in prostate cancer rates are likely due, at least in part, to improved diagnosis and certification of the disease.
Relatively high mortality from testicular cancer was observed in Mexico, with no indication of a decreasing trend in the last decade. As this neoplasm is one of the most curable ones, these patterns point to an inadequate adoption of available drugs (mainly platinum-derived ones) in Mexican men (Bertuccio et al., 2007) .
Mortality data from pancreatic, bladder, and kidney cancer have been available in Mexico only since the late 1990s. For pancreatic and bladder cancer, rates have declined over the last decade, whereas rates have been approximately stable for kidney cancer. Mortality from these neoplasms over more recent years has been low in Mexico compared with other areas of the world, particularly for bladder cancer (La Vecchia et al., 2010) . The reduction in tobacco smoking -the best recognized risk factor for these neoplasms (Boffetta and La Vecchia, 2009 ) -over the previous decades (Shafey et al., 2003) partly or largely explains the decrease in the mortality from pancreatic and bladder cancer, whereas for kidney cancer it is possible that the high prevalence of overweight and obesity -another major recognized risk factor for this neoplasm (Boffetta and La Vecchia, 2009 ) -in the Mexican population (Secretaria de Salud de Mèxico, 2006) have obscured any possible favorable impact of the declines in tobacco smoking.
With reference to lymphohematopoietic cancers, rates over more recent years were comparable with those of Europe (Levi et al., 2000; Bosetti et al., 2008b Bosetti et al., , 2009 ) and North America (Edwards et al., 2010) for HL and for leukemias, whereas the rates were lower for NHL and MM. As in other developed areas of the world, mortality from HL has been decreasing, that from NHL has been increasing, and that from MM has been stable over the last decade. However, no indication of a decline in rates has been observed for leukemias. Together with the proportionally limited decline in HL, this points to inadequacy in the adoption of modern available therapies for largely curable lymphoid neoplasms (Levi et al., 2000; Bosetti et al., 2009; Cortes et al., 2010) .
In conclusion, cancer mortality in Mexico showed persisting low rates and favorable trends mainly for cancer of the lung and other tobacco-related neoplasms. Notwithstanding the high prevalence of overweight and obesity in the Mexican population, there were persisting low death rates from intestinal cancer, although rates have been increasing over recent decades. Though favorable trends were observed, mortality from (cervix) uterine cancer in Mexico remains higher than in North America and Europe, and continues to be a public health priority in Mexican women. Despite the overall favorable trends observed in Mexican cancer mortality, control is necessary for modifiable risk factors for cancer, such as overweight and obesity, tobacco smoking and alcohol drinking, and physical activity. The adoption of modern available therapeutic treatments is also necessary for some cancers amenable to treatment, such as testicular cancer and lymphoid neoplasms.
